Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Publication year range
1.
Sci Data ; 10(1): 585, 2023 09 06.
Article in English | MEDLINE | ID: mdl-37673910

ABSTRACT

Hymenoptera is an order accounting for a large proportion of species in Insecta, among which Chalcidoidea contains many parasitoid species of biocontrol significance. Currently, some species genomes in Chalcidoidea have been assembled, but the chromosome-level genomes of Aphelinidae are not yet available. Using Illumina, PacBio HiFi and Hi-C technologies, we assembled a genome assembly of Eretmocerus hayati (Aphelinidae, Hymenoptera), a worldwide biocontrol agent of whiteflies, at the chromosome level. The assembled genome size is 692.1 Mb with a contig N50 of 7.96 Mb. After Hi-C scaffolding, the contigs was assembled onto four chromosomes with a mapping rate of > 98%. The scaffold N50 length is 192.5 Mb, and Benchmarking Universal Single-Copy Orthologues (BUSCO) value is 95.9%. The genome contains 370.8 Mb repeat sequences and total of 24471 protein coding genes. P450 gene families were identified and analyzed. In conclusion, our chromosome-level genome assembly provides valuable support for future research on the evolution of parasitoid wasps and the interaction between hosts and parasitoid wasps.


Subject(s)
Genome , Wasps , Animals , Benchmarking , Wasps/genetics
2.
Mol Plant Pathol ; 24(8): 882-895, 2023 08.
Article in English | MEDLINE | ID: mdl-37191666

ABSTRACT

Recombination is common in plant viruses such as geminiviruses, but the ecological and pathogenic consequences have been explored only in a few cases. Here, we found that a new begomovirus, tomato yellow leaf curl Shuangbai virus (TYLCSbV), probably originated from the recombination of Ageratum yellow vein China virus (AYVCNV) and tobacco curl shoot virus (TbCSV). Agrobacterium-mediated inoculation showed that TYLCSbV and AYVCNV have similar levels of infectivity on tomato and tobacco plants. However, the two viruses exhibit contrasting specificities for vector transmission, that is, TYLCSbV was efficiently transmitted by the whitefly Bemisia tabaci Mediterranean (MED) rather than by the whitefly B. tabaci Middle East-Asia Minor 1 (MEAM1), whereas AYVCNV was more efficiently transmitted by MEAM1. We also showed that the transmission efficiencies of TYLCSbV and AYVCNV are positively correlated with the accumulation of the viruses in whitefly whole bodies and organs/tissues. The key coat protein amino acids that determine their accumulation are between positions 147 and 256. Moreover, field surveys suggest that MED has displaced MEAM1 in some regions where TYLCSbV was collected. Viral competition assays indicated that TYLCSbV outcompeted AYVCNV when transmitted by MED, while the outcome was the opposite when transmitted by MEAM1. Our findings suggest that recombination has resulted in a shift of vector specificity that could provide TYLCSbV with a potential selective transmission advantage, and the population shift of whitefly cryptic species could have influenced virus evolution towards an extended trajectory of transmission.


Subject(s)
Begomovirus , Hemiptera , Plant Viruses , Animals , Begomovirus/genetics , Plant Diseases
3.
Cells ; 10(7)2021 07 05.
Article in English | MEDLINE | ID: mdl-34359870

ABSTRACT

Begomoviruses cause substantial losses to agricultural production, especially in tropical and subtropical regions, and are exclusively transmitted by members of the whitefly Bemisia tabaci species complex. However, the molecular mechanisms underlying the transmission of begomoviruses by their whitefly vector are not clear. In this study, we found that B. tabaci vesicle-associated membrane protein 2 (BtVAMP2) interacts with the coat protein (CP) of tomato yellow leaf curl virus (TYLCV), an emergent begomovirus that seriously impacts tomato production globally. After infection with TYLCV, the transcription of BtVAMP2 was increased. When the BtVAMP2 protein was blocked by feeding with a specific BtVAMP2 antibody, the quantity of TYLCV in B. tabaci whole body was significantly reduced. BtVAMP2 was found to be conserved among the B. tabaci species complex and also interacts with the CP of Sri Lankan cassava mosaic virus (SLCMV). When feeding with BtVAMP2 antibody, the acquisition quantity of SLCMV in whitefly whole body was also decreased significantly. Overall, our results demonstrate that BtVAMP2 interacts with the CP of begomoviruses and promotes their acquisition by whitefly.


Subject(s)
Begomovirus/physiology , Hemiptera/metabolism , Hemiptera/virology , Insect Proteins/metabolism , Vesicle-Associated Membrane Protein 2/metabolism , Amino Acid Sequence , Animals , Antibodies, Viral/metabolism , Capsid Proteins/metabolism , Insect Proteins/chemistry , Protein Binding , Transcription, Genetic , Vesicle-Associated Membrane Protein 2/chemistry
4.
Mitochondrial DNA B Resour ; 6(2): 397-398, 2021 Feb 08.
Article in English | MEDLINE | ID: mdl-33659691

ABSTRACT

The complete mitochondrial genome was determined for the whitefly Aleyrodes shizuokensis (Hemiptera: Aleyrodidae), the first record from Chinese mainland. The mitochondrial genome is 16,687 bp in length and contains 13 protein-coding genes (PCGs), 22 transfer RNAs, and two ribosomal RNAs. The overall base composition is 33.8% A, 47.0% T, 12.2% G, and 7.0% C. All PCGs start with ATN codon. COX1 ends with a T, and the other 12 PCGs use TAA or TAG as the stop codon. Gene arrangement of the 13 PCGs is identical to that of the giant whitefly Aleurodicus dugesii and greenhouse whitefly Trialeurodes vaporariorum. The resultant Bayesian inference and maximum-likelihood trees based on the sequence data of 13 PCGs support its close relationship with sugarcane whitefly Neomaskellia andropogonis.

5.
Chinese Journal of Surgery ; (12): 1444-1447, 2006.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-288574

ABSTRACT

<p><b>OBJECTIVE</b>To evaluate the efficacy and safety of hepatitis B immunoglobulin (HBIG) by different medicating ways in patients with liver transplantation and to explore the methods for calculating the intravenous loading dosage of HBIG.</p><p><b>METHODS</b>The patients enrolled were randomized into three groups (i.v group, i.m group and domino group). Under the combined utilization with Lamivudine, HBIG was given in different ways during anhepatic phase and the postoperative six days. The physical examination was done, the serum conversion rate of HBsAg was studied, the serum level of HBsAb titer, WBC, PLT, AST, GGT, TBIL, DBIL, CR, PT and PTA were tested daily within the postoperative seven days. The preoperative body weight, serum HBsAg and HBeAg titer were analyzed with the intravenous loading dosage of HBIG by multiple-factor linear regression (Stepwise).</p><p><b>RESULTS</b>Both the average negative-conversion rate of serum HBsAg and the average increasing rate of serum HBsAb titer are significantly faster in i.v group and domino group than that in i.m group within the postoperative four days (P < 0.05). The regression equation to calculate the i.v loading dosage of HBIG (IU) by preoperative criteria was drawn as 1123 + 3.4 x serum HBsAg titer (IU/L) +73 x body weight (kg). There was no linear correlation found between the level of HBeAg and the loading dosage of HBIG. There were no significant difference in body temperature, pulse rate, respiratory rate, blood pressure, WBC, PLT, AST, GGT, TBIL, DBIL, CR, PT and PTA among the three groups within the postoperative seven days (P < 0.05). The rate of the second elevation of serum ALT was 10.3% (3/29), 3.4% (1/29) and 6.7% (2/30) in i.v group, i.m group and domino group, respectively (P < 0.05), and the rate of the local complications (sclerosis, edema, pain) at the injection site was 0, 89.6% (26/29) and 0, respectively (P < 0.05).</p><p><b>CONCLUSIONS</b>Based on the combined utilization of lamivudine and HBIG, the qualified intervention efficacy, less complications could be obtained by medicating HBIG in a domino way (i.v first, followed by i.m), which is worthy to be promoted.</p>


Subject(s)
Humans , Alanine Transaminase , Blood , Antiviral Agents , Therapeutic Uses , Combined Modality Therapy , Drug Therapy, Combination , Hepatitis B , Blood , Therapeutics , Hepatitis B Antibodies , Blood , Hepatitis B Surface Antigens , Blood , Immunization, Passive , Methods , Immunoglobulins , Therapeutic Uses , Lamivudine , Therapeutic Uses , Linear Models , Liver Transplantation , Secondary Prevention , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...